The global pricing and reimbursement environment of the pharmaceutical industry is particularly challenging in the current economic climate. It is essential for pharmaceutical companies to implement effective pricing strategies to ensure cost-effectiveness in a global market.
Informa Life Sciences’ 9th Annual Global Pricing and Reimbursement Congress will provide you with the opportunity to hear policy overviews on leading markets. You will be able to gain insight into how to prepare an effective pricing strategy to maximise profit and ensure market success, making this conference is a must for globally-minded pricing and market access professionals
Hear the latest updates on pricing and reimbursement across Europe: read more
Discover how to use innovative pricing schemes to enhance growth in the pharmaceutical industry from our World Health Organisation representative
Examine the challenges in the pricing and reimbursement strategies for orphan drugs and how you can overcome these
Interact with representatives form healthcare agencies across Europe to find solutions to your pricing and reimbursement queries
Examine innovative pricing and market access schemes which utilise the concepts behind risk-sharing agreements and how to apply these in practice
Do not miss Brian Lovatt, International Health Economist, Vision Healthcare Consultancy, UK discuss 'Pricing and Health Economics' and how it is applied in different markets
AND
Dr. Christian Stallberg, Clifford Chance, UK present on the 'Lastest developments in Pricing and Reimbursement policies in Germany'
AND
Kieron Sparrowhawk, Partner, PriceSpective, UK give an overview of how best to overcome the economic downturn in Europe
"“Good overview of markets and how pharma is reacting”"
"“Interesting and useful meeting”"
Razmic S. Gregorian Jr, Partner, Simon-Kucher & Partners, USA - Presenting on 'Pricing and Reimbursement Systems in Global Markets' on Wednesday 9th February 2011